6167 studies found for:    delta-24
Show Display Options
Rank Status Study
1 Completed Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Procedure: Tenckhoff Catheter placement;   Drug: Ad5-delta24RGD
2 Unknown  Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
Conditions: Brain Tumor;   Recurring Glioblastoma
Intervention: Biological: delta-24-RGD adenovirus
3 Active, not recruiting DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
Conditions: Brain Cancer;   Central Nervous System Diseases
Interventions: Drug: DNX-2401;   Procedure: Tumor Removal
4 Recruiting Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Recurrent Tumor
Intervention: Procedure: DNX2401 and Temozolomide
5 Recruiting DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Single intratumoral injection of DNX-2401;   Drug: interferon gamma
6 Terminated
Has Results
Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer
Conditions: Leukemia;   Lymphoma;   Malnutrition;   Myelodysplastic Syndromes;   Unspecified Childhood Solid Tumor, Protocol Specific;   Weight Changes
Interventions: Dietary Supplement: Ensure;   Dietary Supplement: PediaSure;   Drug: cyproheptadine hydrochloride
7 Unknown  Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis
Condition: Stenosis
Intervention: Drug: atorvastatin
8 Completed
Has Results
Full-time Bangerter Filters Versus Part-time Daily Patching for Moderate Amblyopia in Children
Condition: Amblyopia
Interventions: Device: Bangerter filters;   Device: Patching;   Procedure: Near activities
9 Completed
Has Results
CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: any human insulin or analog insulin(s) given in any regimen by subcutaneous injection
10 Completed
Has Results
Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants
Condition: Schizophrenia
Intervention: Drug: Paliperidone
11 Terminated
Has Results
The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)
Condition: Back Pain
Interventions: Drug: Parathyroid hormone (PTH) (1-84);   Drug: Alendronate
12 Not yet recruiting RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate
Condition: Multiple Sclerosis
Intervention: Drug: Rebif®
13 Enrolling by invitation Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients
Condition: Gastroesophageal Reflux Disease
Intervention: Procedure: Endoscopy
14 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
15 Completed
Has Results
Effect of Orlistat in Body Composition
Conditions: Obesity;   Overweight
Interventions: Drug: Orlistat;   Drug: Placebo
16 Terminated
Has Results
Dynepo Infrequent Dosing Study
Conditions: Anemia;   Kidney Failure
Interventions: Drug: Dynepo (Epoetin delta);   Drug: Dynepo
17 Completed
Has Results
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Condition: HIV Infections
Interventions: Drug: ATV/r;   Drug: DRV/r
18 Not yet recruiting ASIS for Botox in Cervical Dystonia
Conditions: Cervical Dystonia Adults ,;   Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
19 Completed
Has Results
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
Condition: Pain, Postoperative
Interventions: Drug: Naproxen Sodium ER (BAYH6689);   Drug: Naproxen Sodium IR (Aleve, BAYH6689);   Drug: Naproxen Sodium ER Placebo;   Drug: Naproxen Sodium IR Placebo
20 Completed
Has Results
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study
Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Procedure: Laser;   Procedure: Sham laser;   Drug: Sham to ranibizumab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years